Clinical Trials for Bladder Cancer

3 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TherapeuticVICCMD1188
06/08/2012
An Open-Label, Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers
Epidemiology, Observation, OutcomesVICCURO1143
11/01/2011
Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial. Protocol No. 36911
Screen, Detect, DiagnoseVICCMD1286
12/17/2012
Screening Protocol to Detect BRAF V600 Mutation Positive Patients for Enrollment into Clinical Research Studies of Vemurafenib

You do not have JavaScript enabled. This site works better with JavaScript turned on.